Press Releases

Investor E-mail Alert Service: You can automatically receive Press Release alerts via e-mail by subscribing now.

Keyword Search
 
12/03/2013
Novel Molecular Assay for Patient Screening Detects S. aureus and Newly Emerging MRSA Strains Available in the United States
11/27/2013
BD to Present at the 25th Annual Piper Jaffray Healthcare Conference
11/26/2013
BD Board Increases Dividend
11/19/2013
Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market
11/13/2013
BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
11/06/2013
BD Diagnostics Presents Integrated Cervical Cancer Testing Solutions at EUROGIN 2013
11/05/2013
BD Announces Results for 2013 Fourth Fiscal Quarter and Full Year; Provides Fiscal 2014 Guidance
11/05/2013
Q4 2013 Earnings Presentation (PDF)
11/04/2013
BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management
10/28/2013
BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
10/16/2013
Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics
09/27/2013
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
09/27/2013
World Health Organization and BD Announce New Commitment to Address Maternal and Newborn Mortality
09/20/2013
Jury Returns Verdict in RTI vs. BD Lawsuit
09/05/2013
New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
08/30/2013
BD to Present at Investor Healthcare Conferences
08/29/2013
FDA Approves Third Drug in BD Simplist™ Prefilled Injectable Line of Products
08/27/2013
BD ProbeTec™ Trichomonas vaginalis Q(x) Assay Launches on the BD Viper™ System with XTR™ Technology in the United States
08/26/2013
BD Supports the FDA's Proposal to Reclassify Rapid Influenza Tests
08/13/2013
New Syringe Designed to Position More Large Volume Injectable Drugs for Prefill Administration
08/01/2013
BD Announces Results For 2013 Third Fiscal Quarter
08/01/2013
Q3 2013 Earnings Presentation (PDF)
07/30/2013
BD and the College of American Pathologists Announce Strategic Alliance to Support Laboratory Quality and Performance in India and China
07/23/2013
BD Board Declares Dividend
07/08/2013
BD Appoints Christopher Reidy as Chief Financial Officer
07/03/2013
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/21/2013
BD's Latest Pen Needle Innovation Designed to Make Injections Easier for People with Diabetes
06/19/2013
New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
06/18/2013
JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes
06/06/2013
BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
06/04/2013
BD and Heart to Heart International Continue Ongoing Collaboration to Help Improve Healthcare in Haiti with Third Volunteer Service Trip
06/03/2013
New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery
05/24/2013
BD to Present at the Deutsche Bank 38th Annual Health Care Conference
05/22/2013
BD Issues 2012 Sustainability Report
05/21/2013
BD Board Declares Dividend
05/02/2013
BD Announces Results For 2013 Second Fiscal Quarter
05/02/2013
Q2 2013 Earnings Presentation (PDF)
04/23/2013
FDA Approves Second Drug in BD Simplist™ Prefilled Injectable Line of Products
04/17/2013
Nearly 8 Million Healthcare Personnel Come in Contact with Chemotherapy Drugs, According to CDC
04/11/2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard
04/09/2013
New Molecular Assay Provides Healthcare Facilities with a Simple, Efficient Way to Detect Dangerous Superbug
04/08/2013
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
04/08/2013
CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra™ Microbiology Platform
03/28/2013
BD Simplist Presentation
03/27/2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
03/13/2013
BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development
03/12/2013
BD Acquires Cato Software Solutions
03/05/2013
Raymond James Institutional Investors Conference Presentation
03/04/2013
Cowen Health Care Conference Presentation
02/28/2013
BD to Present at Investor Healthcare Conferences
02/28/2013
Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
02/07/2013
BD to Present at Investor Healthcare Conferences
02/05/2013
BD Announces Results for 2013 First Fiscal Quarter
02/05/2013
Q1 2013 Earnings Presentation (PDF)
01/29/2013
BD Board Declares Dividend
01/29/2013
Catherine M. Burzik Elected as BD Director
01/23/2013
BD Announces Webcast of Annual Meeting of Shareholders
01/15/2013
BD PhaSeal™ System Receives Clearance from FDA Under Newly Created ONB Product Code
01/09/2013
JPMorgan Global Healthcare Conference Presentation
01/08/2013
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call